Listril is commonly used to help manage symptoms and conditions associated with significant cardiovascular stress, which generally involves addressing the chronic elevation of pressure within the circulatory system.

Listril is primarily applied across three major therapeutic domains: managing essential hypertension (high blood pressure), providing supportive care for chronic heart failure, and offering cardiac protection after a heart attack (post-myocardial infarction). It is also relevant in conditions where symptoms related to organ-specific functional stress, particularly kidney function in diabetic patients, are a concern.

Quick Fact: Relief for Circulatory Strain The medication helps maintain a sense of stability and is applied in settings marked by temporary physiological imbalance.

The medication offers support by addressing symptom clusters that interfere with daily comfort, such as fatigue and fluid retention. Listril is relevant for managing symptoms that interfere with daily comfort and may help patients cope more steadily during periods of heightened physiological stress. This supportive relief is commonly used in contexts involving heightened systemic burden.

Regulatory References

1. NIH MedlinePlus overview of Lisinopril

Who Can and Cannot Use Listril?

The population eligibility for Listril (Lisinopril) is strictly defined by regulatory authorities based on contraindications, age restrictions, and specific health conditions. This medicine is primarily approved for adult patients and pediatric patients aged 6 years and older for the treatment of hypertension only.

Absolute Contraindications

Listril is contraindicated and must not be used in specific populations:

• Patients with a history of angioedema (hereditary, idiopathic, or related to a previous ACE Inhibitor).
• Women who are pregnant in the second or third trimester.
• Patients taking or within 36 hours of stopping a Neprilysin Inhibitor.
• Patients with diabetes or renal impairment (GFR < 60 mL/min/1.73m^2) who are also receiving aliskiren.

Restrictions and Limitations

Use is not established and is not permitted in children younger than 6 years of age. Furthermore, the drug is not recommended during lactation (breastfeeding). Special caution and a lower starting dose are required for adults with severe renal impairment (Creatinine Clearance < 30 mL/minute) and in patients who are volume- or salt-depleted. Listril must not be initiated in patients who are hemodynamically unstable following an acute heart attack.

Interactions with other medicines and products

Listril (Lisinopril) has officially documented interaction patterns that primarily relate to additive effects on blood pressure, potassium levels, and renal function. The regulatory documentation strictly identifies several combinations and constraints.

Contraindicated and Time-Separated Combinations

• Sacubitril/Valsartan: Co-administration is formally contraindicated due to the significant risk of angioedema. Lisinopril must not be started until 36 hours have passed since the last dose of Sacubitril/Valsartan.
• Aliskiren: Co-administration is contraindicated in patients with Diabetes Mellitus or documented Renal Impairment (GFR < 60 mL/min/1.73 m^2) due to increased risk of hyperkalemia, hypotension, and declining renal function.

Pharmacodynamic and Exposure Interactions

• Potassium-Sparing Diuretics and Potassium Supplements/Salt Substitutes: Concomitant use with these agents carries a documented risk of hyperkalemia (elevated serum potassium levels).
• Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Combining Lisinopril with NSAIDs may cause an attenuation of the antihypertensive effect and an increased risk of worsening renal function, particularly in patients with pre-existing renal impairment.
• Lithium: Co-administration has been reported to cause reversible increases in serum lithium concentrations and toxicity, as Lisinopril reduces the renal clearance of Lithium.

Food/Metabolic Note

• Food: The regulatory documentation states that the absorption of Lisinopril is not influenced by the presence of food. The drug does not undergo significant metabolism by the CYP enzyme system. The official interaction profile defines severe restrictions based on additive hemodynamic and electrolyte effects, requiring mandatory timing rules for specific combinations.

Listril is a small molecule that acts as a selective agonist, primarily targeting the parathyroid hormone receptor type 1 (PTHR1) expressed on the surface of osteoblasts. Binding to PTHR1 activates the receptor, initiating intracellular signal transduction. This activation specifically modulates the PTHR1/cyclic AMP (cAMP) pathway, leading to a transient but significant increase in cAMP levels within the osteoblast. The resulting shift in signaling initiates a subsequent anabolic cascade. This cascade involves the differential expression of genes related to bone matrix synthesis, progenitor cell differentiation, and the production of local growth factors. This modification of the signaling environment affects the balance between osteoblastic bone formation and osteoclastic bone resorption at the cellular level, selectively stimulating bone-building cellular processes.

Listril is administered exclusively by the oral route, typically as a single dose once daily. The medication is available as tablets across several strengths, as well as an oral solution at 1 mg/mL for precise measurements. The tablets may be taken with or without food; however, administration at approximately the same time each day is required to maintain consistent use patterns.

The initial dosage is highly dependent on the condition being treated. For managing hypertension, a common starting dose is 10 mg once daily. For the treatment of heart failure or following an acute myocardial infarction, a lower initial dose of 2.5 mg or 5 mg once daily is often utilized. Subsequent dose adjustments, or titrations, are performed over specific, established intervals, typically every 1 to 4 weeks, up to a maximum daily dose of 40 mg.

Specialized instructions govern use in certain populations. Patients with impaired renal function must be initiated on a reduced dose, such as 2.5 mg or 5 mg once daily. A weight-based regimen starting at 0.07 mg/kg is outlined for pediatric patients (ages six and older). If a dose is missed, the recommendation is to skip the forgotten dose and resume the normal once-daily schedule at the next scheduled time, without taking an extra amount.

Research evidence / Overview of Studies for Listril

Evidence for use in Managing High Blood Pressure (Essential Hypertension)

Research exploring Lisinopril for high blood pressure has primarily relied on Randomized Controlled Trials (RCTs). These studies were designed to compare the medicine against both an inactive substance (placebo) and other established medications. Researchers examined the specific changes in blood pressure readings that were measured in adults with mild to moderate high blood pressure, as well as in specific groups like the elderly. Dedicated studies was evaluated in the pediatric population—children aged 6 years and older—to understand how the medicine might apply in this younger group.

Trials reported specific patterns in blood pressure measurements across the study duration when compared to placebo and to other active treatments. These findings contribute to the broader evidence landscape regarding how this class of medicine was studied for application in elevated blood pressure.

Evidence for use in Supporting Chronic Heart Failure

For patients with chronic heart failure, the research base includes large-scale, long-term Randomized Controlled Trials, such as the ATLAS trial. These studies typically involved patients who were already receiving other standard medications. Researchers examined outcomes related to all-cause mortality, cardiovascular mortality, and the number of times patients required hospitalization for heart issues over several years. Additionally, studies monitored physiological strain or stress by evaluating changes in heart function markers, such as the Left Ventricular Ejection Fraction (LVEF), and changes in clinical status assessments.

Long-term trials reported patterns observed in the frequency of cardiovascular events and death over the studied follow-up periods when the active agent was compared to a placebo. Certainty remains low on the ideal dosage for heart failure management, as evidence of differences between intermediate and high doses for all-cause mortality findings were mixed in some studies.

Evidence for use Following a Heart Attack (Post-Myocardial Infarction)

The research exploring the use of Lisinopril after a heart attack is based on large, multi-center Randomized Controlled Trials like the GISSI-3 trial. These studies were conducted during periods of increased symptom activity and typically involved initiating the medication shortly (within 24 hours) after the event. Researchers explored outcomes reflecting daily functioning or activity level, primarily focusing on all-cause mortality at defined intervals and the incidence of non-fatal cardiac failure. The populations studied included stable patients, including those considered high-risk, such as patients with diabetes.

What is Still Uncertain About the Research for Listril

A key limitation is that many findings, particularly for long-term cardiovascular outcomes like preventing stroke or death in hypertension, are based on the collective evidence available for the entire ACE inhibitor class of medicines, rather than being derived solely from Lisinopril-specific data. Evidence quality varies across studies, and for certain specialized uses, such as in patients who do not have high blood pressure but have kidney strain, data are still emerging and not yet fully established. The research provides context but not individual predictions, and study results reflect the specific conditions under which they were conducted.

Common questions about Listril (FAQ)

Q: Does Listril require a prescription?

Listril, which contains the active ingredient Lisinopril, is officially categorized by regulatory agencies as a prescription-only medication. It is not available for purchase without a valid prescription from a licensed healthcare professional.

Q: Does alcohol consumption affect the safety or effectiveness of Listril?

Official warnings indicate that alcohol consumption may have an additive effect on the blood pressure-lowering action of Listril. This combination may increase the reported occurrence of dizziness, lightheadedness, or feeling faint. Patients are generally advised to discuss alcohol consumption with a healthcare provider.

Q: Is Listril considered a long-term medication?

The medicine is primarily used to help control chronic conditions, such as high blood pressure and heart failure. For certain patient populations, such as those with left ventricular dysfunction following a heart attack, therapy continuation is supported by long-term data for chronic conditions.

Q: Does Listril cause any issues with driving?

Because Listril can cause side effects like dizziness, lightheadedness, or fainting, especially when treatment begins or when the dose is changed, official sources suggest caution. Patients should know how the medicine affects them before engaging in activities like driving or operating machinery.

Q: What should I do if I suspect an interaction with another medicine?

Official patient guidance emphasizes the importance of informing a doctor or pharmacist about all medicines, supplements, or dietary products currently being taken. Regulatory guidance emphasizes the importance of sharing this information with a healthcare professional before starting or adjusting Listril, as serious complications can arise from certain drug combinations.

Q: Are there different strengths of Listril tablets available?

Yes, regulatory documents confirm that the tablets containing the active ingredient Lisinopril are supplied in a range of strengths to allow for personalized treatment. These commonly include strengths such as 2.5 mg, 5 mg, 10 mg, 20 mg, 30 mg, and 40 mg for oral use.

Q: Why is it important to know all medicines I am taking with Listril?

It is crucial because Listril has established interaction patterns with other medicines, which can lead to additive effects. Regulatory documents outline that certain combinations can cause health risks, including very low blood pressure (hypotension), dangerously high potassium levels (hyperkalemia), or problems with kidney function.

Q: Can Listril cause weight gain?

Weight gain is not explicitly listed as a common adverse effect in official clinical trial data. However, regulatory safety reports do note the potential for swelling or fluid retention. Swelling or fluid retention are symptoms that may relate to documented adverse reactions, such as kidney issues or angioedema (severe swelling).

Q: How quickly does Listril typically start to work?

According to the clinical pharmacology information, the blood pressure-lowering effect of the active ingredient Lisinopril generally begins within two hours after taking a dose. The maximum blood pressure-lowering action is usually observed approximately six hours after administration.

Q: Is there a generic version of Listril available?

Yes. The active compound in Listril, known as Lisinopril, is available as an FDA-approved generic medication from multiple manufacturers. The generic version contains the same active ingredient and is designated as bioequivalent to the brand-name product.

Q: What if Listril doesn't seem to be working after a few weeks?

Dosing must be guided by a healthcare professional. Official guidelines for treating high blood pressure and heart failure allow for dose adjustments based on individual response, typically reviewed over intervals ranging from one to four weeks. If the desired result is not observed, the healthcare provider may decide to adjust the regimen.

Q: Is there any risk of dependency with Listril?

No. Listril is an ACE inhibitor and is not classified by regulatory agencies as a controlled substance. Official sources indicate that there is no known risk of physical dependence or addiction associated with the proper use of this medication.

Q: Is a dry mouth a common side effect of Listril?

Official safety profiles list side effects by frequency. While a dry mouth is a reported adverse reaction, regulatory data indicates it is not one of the most frequently observed side effects in trials, such as cough or headache.

Q: Has Listril been studied in combination with other treatments for [condition]?

Yes. For specific approved uses, such as the treatment of heart failure, regulatory approval is based on clinical trials where the medicine was administered in combination with other standard therapies, including certain diuretics and digitalis.

Q: Do I need to change my diet while taking Listril?

Official documents state that there are no general dietary restrictions, as food does not affect the medicine's absorption. However, regulatory sources strongly caution against the use of potassium supplements or salt substitutes containing potassium, as combining them with Listril can cause dangerously high potassium levels (hyperkalemia).

Q: Are there specific instructions for stopping Listril?

Official regulatory instructions specify that Listril must be discontinued immediately if a serious, potentially life-threatening side effect called angioedema (swelling of the face, tongue, or throat) occurs. It must also be stopped immediately if pregnancy is detected.

Q: Is Listril commonly prescribed for anxiety/sleep issues?

Official regulatory approval (indications for use) is strictly limited to treating high blood pressure, heart failure, and for use after a heart attack. Prescribing for conditions such as anxiety or sleep issues is not addressed in the official product labeling.

Q: Does Listril have any reported sexual side effects?

Regulatory safety documents include reports of sexual side effects. These can include a decreased interest in sexual activity and difficulties with maintaining an erection. These effects are typically categorized among the less common adverse reactions.

Q: Can Listril be taken by someone with diabetes?

Listril can generally be used by people with diabetes. However, regulatory documents state a strict contraindication: the medicine must not be used in diabetic patients who are also taking the drug aliskiren.

Q: What are the most serious, but rare, side effects of Listril?

Official safety data highlights several serious adverse reactions that are infrequently reported. These include life-threatening swelling (Angioedema), acute kidney injury (Acute Renal Failure), and problems with the liver (Hepatic Failure). Official labeling contains specific warnings about these risks.

Q: What is the history of Listril’s approval?

The active ingredient in Listril, Lisinopril, was originally approved by the U.S. Food and Drug Administration (FDA) in December 1987. It was initially authorized for the treatment of high blood pressure (hypertension).

Q: Is Listril effective for all stages of [condition]?

The body of clinical evidence primarily covers certain patient profiles, such as those with mild to moderate high blood pressure, and does not address every possible stage or severity of every approved condition. Research is focused on the specific conditions studied in clinical trials.

Q: What is the half-life of Listril?

According to the official pharmacokinetic data, the average elimination half-life of the active ingredient, Lisinopril, is approximately 12.6 hours in patients who have normal, healthy kidney function. The half-life refers to the time it takes for half of the medicine to be cleared from the body.

Q: Does Listril affect fertility in men or women?

Non-clinical studies using animal models did not show any impact on fertility of male or female subjects. However, due to the established risk of injury or death to the fetus, Listril is contraindicated during the second and third trimesters of pregnancy.

How to Store and Dispose of Listril (Lisinopril)

The storage and disposal of Listril tablets must align with official regulatory requirements to maintain product stability and ensure public safety.

Official Storage Conditions

Listril must be stored at controlled room temperature, specifically between 20°C and 25°C (68°F and 77°F). The medication must be protected from moisture, direct light, and kept from freezing or excess heat. It is essential to keep the tablets in the tightly closed container they came in and store them out of the sight and reach of children.

Disposal Instructions

Unused or expired Listril should be disposed of using a community drug take-back program as the preferred method. If a take-back program is unavailable, the tablets should be mixed with an undesirable substance (such as dirt or coffee grounds) and placed in a sealed container before discarding them in the household trash. Listril is not recommended for flushing down the toilet or sink.